Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape
J. C. Brown, D. H. Goldhill, J. Zhou, T. P. Peacock, R. Frise, N. Goonawardane, L. Baillon, R. Kugathasan, A. Pinto, P. F. McKay, J. Hassard, M. Moshe, A. Singanayagam, T. Burgoyne, the ATACCC Investigators, , W. S. Barclay
This study shows that SARS-CoV-2 variant B.1.1.7 does not replicate better in airway cells or escape antibodies, suggesting its increased transmissibility is due to other factors.
bioRxiv · Feb 24, 2021 · PreprintMicrobiology